United States · FDA National Drug Code directory
Incassia
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-925_0caa1c4e-9536-49b0-a523-b6a6676434ba
- Product NDC
- 65862-925
- Form
- TABLET
- Composition / generic term
- NORETHINDRONE
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160923
- Source listing expiry
- 20261231
Source-listed ingredients
- NORETHINDRONE — .35 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (65862-925-28) / 1 TABLET in 1 BLISTER PACK · 65862-925-28
- 3 BLISTER PACK in 1 CARTON (65862-925-85) / 1 TABLET in 1 BLISTER PACK · 65862-925-85
- 6 BLISTER PACK in 1 CARTON (65862-925-86) / 1 TABLET in 1 BLISTER PACK · 65862-925-86
- 1 POUCH in 1 CARTON (65862-925-87) / 1 TABLET in 1 POUCH · 65862-925-87
- 3 POUCH in 1 CARTON (65862-925-88) / 1 TABLET in 1 POUCH · 65862-925-88
- 6 POUCH in 1 CARTON (65862-925-92) / 1 TABLET in 1 POUCH · 65862-925-92
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →